| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.22 | 0.0002 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.22 | 0.0002 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |